- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Madrigal Pharmaceuticals
Market Cap: US$11.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$512.39
7D
-3.7%
1Y
56.8%
Insmed
Market Cap: US$29.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$135.17
7D
-6.4%
1Y
94.0%
Ionis Pharmaceuticals
Market Cap: US$12.1b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$73.27
7D
-3.2%
1Y
146.7%
Alnylam Pharmaceuticals
Market Cap: US$40.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$305.54
7D
-1.3%
1Y
21.5%
Ascendis Pharma
Market Cap: US$14.2b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$229.27
7D
n/a
1Y
n/a
Neurocrine Biosciences
Market Cap: US$12.8b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$127.68
7D
-4.2%
1Y
19.6%
BeOne Medicines
Market Cap: US$33.4b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$300.80
7D
-7.1%
1Y
22.8%
BridgeBio Pharma
Market Cap: US$14.2b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$73.28
7D
-4.5%
1Y
101.8%
AbbVie
Market Cap: US$351.5b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$198.71
7D
-4.6%
1Y
6.8%
Jazz Pharmaceuticals
Market Cap: US$12.1b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$196.52
7D
-3.4%
1Y
77.4%
Eli Lilly
Market Cap: US$791.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$883.96
7D
-4.6%
1Y
-0.07%
Natera
Market Cap: US$28.9b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$203.75
7D
-2.2%
1Y
32.5%
Royalty Pharma
Market Cap: US$29.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$49.38
7D
-1.2%
1Y
53.4%
Viatris
Market Cap: US$17.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$14.59
7D
-0.6%
1Y
79.5%
Elanco Animal Health
Market Cap: US$11.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.75
7D
-3.9%
1Y
140.5%
BioMarin Pharmaceutical
Market Cap: US$10.2b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$53.18
7D
-2.7%
1Y
-16.0%
Waters
Market Cap: US$30.4b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$309.87
7D
-5.5%
1Y
-8.3%